🇺🇸 FDA
Pipeline program

Risperidone

RB-US-09-0009

Phase 2 small_molecule completed

Quick answer

Risperidone for Schizophrenia is a Phase 2 program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Schizophrenia
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials